Literature DB >> 2714609

The significance of diminutive colonic polyps found at flexible sigmoidoscopy.

M E Ryan1, R G Norfleet, J P Kirchner, K Parent, J F Nunez, R A Rhodes, J B Wyman.   

Abstract

In order to determine the importance of identification and follow-up of diminutive colonic polyps (DCPs) (i.e., those less than or equal to 5 mm in diameter), we studied 3006 patients undergoing flexible sigmoidoscopy. DCPs were found in 315 patients (10.5%). Biopsy of these lesions showed them to be nonneoplastic in 187 patients (59.4%) and neoplastic in 128 (40.6%). Overall, 35% of all DCPs found were neoplastic. Gross appearance of the lesions was found to be an unreliable means of predicting their histologic makeup. Of the 128 patients with neoplastic DCPs, 73 underwent further examination with barium enema and colonoscopy. Synchronous lesions were found in 57.5%. In 10 patients, synchronous lesions were of significance, including carcinomas, adenomas greater than or equal to 8 mm in diameter, or severely dysplastic adenomas. We conclude that all DCPs discovered at sigmoidoscopy should be biopsied and in patients in whom DCPs are found to be neoplastic, colonoscopy should be undertaken to search for proximal synchronous lesions.

Entities:  

Mesh:

Year:  1989        PMID: 2714609     DOI: 10.1016/s0016-5107(89)72714-0

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  3 in total

1.  An appraisal of small and diminutive colonic polyps.

Authors:  J M Cosgrove; W I Wolff; N Tenenbaum; I B Margolis
Journal:  Surg Endosc       Date:  1991       Impact factor: 4.584

2.  A combined flexible sigmoidoscopy and double-contrast barium enema service: initial experience.

Authors:  R M Mendelson; P J Kelsey; T Chakera
Journal:  Abdom Imaging       Date:  1995 May-Jun

Review 3.  Is the distal hyperplastic polyp a marker for proximal neoplasia?

Authors:  Sachin Dave; Siu Hui; Kurt Kroenke; Thomas F Imperiale
Journal:  J Gen Intern Med       Date:  2003-02       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.